Zacks Company Profile for Bio-Rad Laboratories, Inc. (BIO.B : NYSE) |
|
|
|
Company Description |
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Number of Employees: |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $250.08 |
Daily Weekly Monthly
 |
20 Day Moving Average: 28 shares |
Shares Outstanding: 27.21 (millions) |
Market Capitalization: $6,805.43 (millions) |
Beta: 0.81 |
52 Week High: $359.22 |
52 Week Low: $225.29 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
0.00% |
-5.42% |
12 Week |
11.00% |
-6.87% |
Year To Date |
-23.19% |
-28.06% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
Norman Schwartz - Chief Executive Officer and Chairman
Norman Schwartz - President and Director
Roop K. Lakkaraju - Chief Financial Officer and Executive Vice Preside
Christine A. Tsingos - Vice President;Chief Financial Officer
Jeffrey L. Edwards - Director
|
|
Peer Information
Bio-Rad Laboratories, Inc. (CORR.)
Bio-Rad Laboratories, Inc. (RSPI)
Bio-Rad Laboratories, Inc. (CGXP)
Bio-Rad Laboratories, Inc. (BGEN)
Bio-Rad Laboratories, Inc. (GTBP)
Bio-Rad Laboratories, Inc. (RGRX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 090572108
SIC: 3826
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/07/25
|
|
Share - Related Items
Shares Outstanding: 27.21
Most Recent Split Date: 3.00 (2.00:1)
Beta: 0.81
Market Capitalization: $6,805.43 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: 0.00 |
Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: 0.00 |
Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/07/25 |
|
|
|
|